Cite
research paper Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
MLA
Raje, Noopur, et al. “Research Paper Tumour Cell/Dendritic Cell Fusions as a Vaccination Strategy for Multiple Myeloma.” British Journal of Haematology, vol. 125, no. 3, May 2004, pp. 343–52. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2004.04929.x.
APA
Raje, N., Hideshima, T., Davies, F. E., Chauhan, D., Treon, S. P., Young, G., Tai, Y.-T., Avigan, D., Gong, J., Schlossman, R. L., Richardson, P., Kufe, D. W., & Anderson, K. C. (2004). research paper Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma. British Journal of Haematology, 125(3), 343–352. https://doi.org/10.1111/j.1365-2141.2004.04929.x
Chicago
Raje, Noopur, Teru Hideshima, Faith E. Davies, Dharminder Chauhan, Steven P. Treon, Gloria Young, Yu-Tzu Tai, et al. 2004. “Research Paper Tumour Cell/Dendritic Cell Fusions as a Vaccination Strategy for Multiple Myeloma.” British Journal of Haematology 125 (3): 343–52. doi:10.1111/j.1365-2141.2004.04929.x.